VG Life Sciences Inc. (VGLS)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Apr 24, 2025, 4:00 PM EDT
VG Life Sciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | 2005 - 2009 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '15 Sep 30, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | 2005 - 2009 |
| Cash & Equivalents | 0.02 | 0.03 | 0.71 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Cash & Short-Term Investments | 0.02 | 0.03 | 0.71 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Cash Growth | -57.43% | -95.24% | 11620.44% | 5.29% | -19.99% | -54.16% | Upgrade
|
| Prepaid Expenses | 0.02 | 0.21 | 0.08 | - | - | - | Upgrade
|
| Other Current Assets | - | - | - | - | 0 | 0.01 | Upgrade
|
| Total Current Assets | 0.04 | 0.25 | 0.79 | 0.01 | 0.01 | 0.02 | Upgrade
|
| Long-Term Investments | - | - | - | - | 0.1 | 0.1 | Upgrade
|
| Other Intangible Assets | 1.08 | 1.08 | 1.08 | 1.08 | 2.98 | 2.98 | Upgrade
|
| Total Assets | 1.12 | 1.32 | 1.87 | 1.08 | 3.09 | 3.1 | Upgrade
|
| Accounts Payable | 0.84 | 0.71 | 0.41 | 0.39 | 0.56 | 0.54 | Upgrade
|
| Accrued Expenses | 0.3 | 0.6 | 0.54 | 0.61 | 1.05 | 0.81 | Upgrade
|
| Short-Term Debt | 3.38 | 3.86 | 3.21 | 3.57 | 0.79 | 0.59 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | 0.41 | 1 | Upgrade
|
| Other Current Liabilities | 0.94 | 0.66 | 2.18 | 0.71 | 0 | 0.2 | Upgrade
|
| Total Current Liabilities | 5.46 | 5.83 | 6.33 | 5.28 | 2.81 | 3.14 | Upgrade
|
| Long-Term Debt | - | - | - | - | 1.29 | 1.97 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 0 | 0 | Upgrade
|
| Total Liabilities | 5.46 | 5.83 | 6.33 | 5.28 | 4.1 | 5.11 | Upgrade
|
| Common Stock | 0.01 | 0 | 0 | 0 | 0.09 | 0.06 | Upgrade
|
| Additional Paid-In Capital | 104.85 | 100.79 | 94.61 | 87.46 | 80.14 | 73.8 | Upgrade
|
| Retained Earnings | -109.84 | -105.97 | -99.78 | -92.36 | -81.28 | -75.86 | Upgrade
|
| Comprehensive Income & Other | - | - | - | - | -0.01 | -0.01 | Upgrade
|
| Total Common Equity | -4.98 | -5.17 | -5.17 | -4.9 | -1.06 | -2.02 | Upgrade
|
| Minority Interest | 0.64 | 0.66 | 0.7 | 0.7 | 0.04 | 0 | Upgrade
|
| Shareholders' Equity | -4.34 | -4.51 | -4.47 | -4.2 | -1.01 | -2.01 | Upgrade
|
| Total Liabilities & Equity | 1.12 | 1.32 | 1.87 | 1.08 | 3.09 | 3.1 | Upgrade
|
| Total Debt | 3.38 | 3.86 | 3.21 | 3.57 | 2.49 | 3.56 | Upgrade
|
| Net Cash (Debt) | -3.36 | -3.83 | -2.49 | -3.56 | -2.48 | -3.55 | Upgrade
|
| Net Cash Per Share | -0.06 | -0.14 | -0.30 | -1.66 | -2.02 | -3.83 | Upgrade
|
| Filing Date Shares Outstanding | 107.88 | 61.58 | 17.46 | 3.12 | 1.55 | 1.05 | Upgrade
|
| Total Common Shares Outstanding | 101.5 | 46.22 | 17.46 | 3.12 | 1.55 | 1.05 | Upgrade
|
| Working Capital | -5.42 | -5.58 | -5.55 | -5.27 | -2.8 | -3.12 | Upgrade
|
| Book Value Per Share | -0.05 | -0.11 | -0.30 | -1.57 | -0.68 | -1.92 | Upgrade
|
| Tangible Book Value | -6.06 | -6.25 | -6.25 | -5.97 | -4.04 | -5 | Upgrade
|
| Tangible Book Value Per Share | -0.06 | -0.14 | -0.36 | -1.92 | -2.60 | -4.77 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.